Unverified Commit 7f210d38 authored by liziwl's avatar liziwl Committed by GitHub
Browse files

批量新增 5 个讲座 - 2026-04-04 13:16 (#244)

* Add 2026-03-26T16-00-00_张万斌.md

* Add 2026-03-26T16-00-00_张万斌.md

* Add 2026-03-26T14-30-00_孟建.md

* Add 2026-03-25T12-30-00_Hannah_Bradbury.md

* Add 2026-03-24T10-00-00_周来生.md

* Update README.md (TOC)
parent 06651f72
Loading
Loading
Loading
Loading
+1 −1
Original line number Diff line number Diff line
# 《南科大讲堂 第430期》周来生:中国与北美口腔医学教育体系的比较与探讨

* 题目: 中国与北美口腔医学教育体系的比较与探讨
* 主讲人:周来生 @ 加拿大工程院院士,美国医学与生物工程院院士,波士顿大学终身荣誉教授,上海交通大学瑞金医院广慈桂冠教授
* 主讲人:周来生 @ 波士顿大学, 上海交通大学瑞金医院
* 时间:2026年3月24日 10:00-12:00
* 地点:理学院1142报告厅

+15 −0
Original line number Diff line number Diff line
# 《2026春季CLE工作坊 第2期》Hannah Bradbury:自然表达:利用习语和日常用语提升对话技巧

* 题目: 自然表达:利用习语和日常用语提升对话技巧
* 主讲人:Hannah Bradbury @ SUSTech
* 时间:2026年3月25日 12:30-13:30
* 地点:SUSTech Study Lounge (Second Floor Above Starbuks)

## 主讲人简介
暂无简介

## 讲座简介
暂无摘要

## 海报链接
![](https://gtimg.liziwl.cn/post-img/2026-03-25T12-30-00_Hannah_Bradbury.jpg)
 No newline at end of file
+1 −1
Original line number Diff line number Diff line
# 《南科大讲堂第429期 人文南科讲堂第2期》孟建 教授:现代文明与媒介发展
# 《南科大讲堂 第429期 / 人文南科讲堂 第2期》孟建 教授:现代文明与媒介发展

* 题目: 现代文明与媒介发展
* 主讲人:孟建 教授 @ 复旦大学
+2 −2
Original line number Diff line number Diff line
@@ -6,10 +6,10 @@
* 地点:理学院一楼化学系C1038报告厅

## 主讲人简介
Wanbin Zhang received his B.S. and M.S. from East China University of Science and Technology (ECUST) in 1985 and 1988, respectively. He earned his Ph.D. at Osaka University in 1997 under the supervision of Prof. Isoo Ikeda. Following his Ph.D., he remained at Osaka University as an Assistant Professor until 2001, after which he continued his career as a Research Fellow at Mitsubishi Chemical Corporation in 2003. Since 2003, he has been a professor in the School of Chemistry and Chemical Engineering at Shanghai Jiao Tong University (SJTU). He was promoted to Distinguished Professor in 2013 and subsequently appointed as Chair Professor in 2021, followed by the K. C. Wong Chair Professor in 2025. He has been appointed as Director of Shanghai key laboratory for Molecular Engineering of Chiral Drugs since 2017. He has long been engaged in fundamental and applied research in the field of asymmetric catalysis. He has published more than 300 research papers in internationally peer-reviewed journals including Science, Nat. Chem., J. Am. Chem. Soc., Angew. Chem.; with over 70 patents granted in China and abroad. Several asymmetric catalytic technologies derived from his discoveries have already been applied in industry. He was elected as an Academician of the Chinese Academy of Sciences, a Fellow of the Chinese Chemical Society, National High-Level Talent Special Support Programs (10,000 Talents Program) - Distinguished Teacher, and a Shanghai Model Worker. He received the National Natural Science Award (2nd class, 2023), the first class prize of the China Industry-University-Research Cooperation Innovation Achievement Award (2022), and the Baosteel Outstanding Teacher Special Prize (2024).
暂无简介

## 讲座简介
We have focused on asymmetric catalysis from the viewpoint of activity and selectivity for more than 20 years and developed a series of novel chiral ligands or catalysts and highly efficient asymmetric catalytic systems based on angle control and synergistic promotion strategies, respectively. The research achievements included: 1) the development of novel chiral bicyclic imidazole organocatalysts, which were applied for the first example of the catalytic asymmetric synthesis of P-stereogenic phosphoric acid derivatives; 2) the development of several novel bimetallic catalytic systems, which were applied for the first example of stereodivergent dual catalysis involving two metal catalysts; 3) the synergistic catalytic effect of CH···HC weak attractive interactions between the chiral ligand and the substrate was found to be crucial for reactivity and stereocontrol in rare or earth-abundant metal-catalyzed asymmetric hydrogenation. Importantly, key technological breakthroughs have been achieved for the industrial synthesis of several important chiral compounds, such as the fragrance including Menthol, Carvone and Camphorenal, antimalarial drug Artemisinin, anti-tuberculosis drug Bedaquiline, anti-epileptic drug Brivaracetam, and antiviral drug Remdesivir. Subsequent, the first production line of Menthol with an annual output of ten thousand tons in China has been built by Wanhua Chemical Group Co., Ltd and the first asymmetric catalytic production line of bedaquiline and brivaracetam in the world has been built by Aurisco and Aurisco Pharmaceutical. In addition, Wanxiang Technology Co., Ltd. has built a production line with an annual output of >3,000 tons including (R)-Carvone, Carvacro, Campholenic aldehyde, Brahmanol etc.
暂无摘要

## 海报链接
![](https://gtimg.liziwl.cn/post-img/2026-03-26T16-00-00_%E5%BC%A0%E4%B8%87%E6%96%8C.jpg)
 No newline at end of file
+5 −1
Original line number Diff line number Diff line
@@ -39,9 +39,13 @@
- 10:30 - [《大湾区物理讲堂 2026年第3期》周磊 教授:超构表面光场调控:从界面相位到平面光学](2026-03-26T10-30-00_周磊.md)
- 14:30 - [《系统生物学前沿讲座第16期》崔文平 博士后研究员:人工与生物系统中的学习——从上下文学习相变到动物行为学习](2026-03-26T14-30-00_崔文平.md)
- 14:30 - [《Math Colloquium 第313期》雷震 讲席教授:边界层理论](2026-03-26T14-30-00_雷震.md)
- 14:30 - [《南科大讲堂第429期 人文南科讲堂第2期》孟建 教授:现代文明与媒介发展](2026-03-26T14-30-00_孟建.md)
- 14:30 - [《南科大讲堂 第429期 / 人文南科讲堂 第2期》孟建 教授:现代文明与媒介发展](2026-03-26T14-30-00_孟建.md)
- 16:00 - [《科学大讲堂 第232期》张万斌 院士:不对称催化合成新进展](2026-03-26T16-00-00_张万斌.md)

## 2026-03-25

- 12:30 - [《2026春季CLE工作坊 第2期》Hannah Bradbury:自然表达:利用习语和日常用语提升对话技巧](2026-03-25T12-30-00_Hannah_Bradbury.md)

## 2026-03-24

- 10:00 - [《南科大讲堂 第430期》周来生:中国与北美口腔医学教育体系的比较与探讨](2026-03-24T10-00-00_周来生.md)